Physician profile
Rameez Raja
NPI 1013564715
$523.51
in general payments reported to CMS, 2019-2025
8 companies · $126 in 2025
The $126 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.19 · 2021: $18.03 · 2022: $169 · 2023: $30.48 · 2024: $168 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerr Corporation | $184.44 | 2022-2023 | Optibond Solo Plus |
| Ivoclar Vivadent, INC. | $135.91 | 2024 | Cervitec |
| Voco America INC. | $87.26 | 2025 | Structur Premium, Voco Profluorid Varnish, Grandio Blocs |
| Philips North America LLC | $48.28 | 2019-2024 | (E55) Oral Health Care Und |
| Align Technology, INC. | $23.00 | 2025 | Invisalign |
| Solventum Corporation | $15.26 | 2025 | 3m Scotchbond, 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Relyx |
| Nobel Biocare USA | $15.24 | 2023 | Nobelactive |
| Zest Holdings, LLC | $14.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rameez Raja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.